206 related articles for article (PubMed ID: 2059967)
21. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
[TBL] [Abstract][Full Text] [Related]
22. In staphylococcus enterotoxin B (SEB)-stimulated human PBMC, the LAK activity of non-T cells might have a major role in the mechanism of glomerular endothelial cells' injury.
Seprényi G; Shibata T; Onody R; Kohsaka T
Immunobiology; 1997 Jun; 197(1):44-54. PubMed ID: 9241530
[TBL] [Abstract][Full Text] [Related]
23. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells.
Coppola MA; Blackman MA
Int Immunol; 1997 Sep; 9(9):1393-403. PubMed ID: 9310843
[TBL] [Abstract][Full Text] [Related]
24. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells.
Hedlund G; Dohlsten M; Lando PA; Kalland T
Cell Immunol; 1990 Sep; 129(2):426-34. PubMed ID: 2383900
[TBL] [Abstract][Full Text] [Related]
26. Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
Kuge S; Miura Y; Nakamura Y; Mitomi T; Habu S; Nishimura T
J Immunol; 1995 Feb; 154(4):1777-85. PubMed ID: 7836762
[TBL] [Abstract][Full Text] [Related]
27. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells.
Dohlsten M; Sundstedt A; Björklund M; Hedlund G; Kalland T
Int J Cancer; 1993 May; 54(3):482-8. PubMed ID: 8509223
[TBL] [Abstract][Full Text] [Related]
28. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
29. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
31. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
Xiao J; Brahmi Z
Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
[TBL] [Abstract][Full Text] [Related]
32. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.
Masewicz S; Ledbetter JA; Martin P; Mickelson E; Hansen JA; Odum N
Hum Immunol; 1993 Mar; 36(3):142-8. PubMed ID: 8320132
[TBL] [Abstract][Full Text] [Related]
34. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
[TBL] [Abstract][Full Text] [Related]
35. Mycoplasma arthritidis mitogen up-regulates human NK cell activity.
D'Orazio JA; Cole BC; Stein-Streilein J
Infect Immun; 1996 Feb; 64(2):441-7. PubMed ID: 8550189
[TBL] [Abstract][Full Text] [Related]
36. Primary cytotoxicity of SEB-activated human PBMC and separated CD8+ and CD4+ T lymphocytes elicited by two different stimulation protocols.
Seprényi G; Abe J; Kohsaka T
Immunol Cell Biol; 1996 Dec; 74(6):483-9. PubMed ID: 8989585
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes.
Roberts AI; Blumberg RS; Christ AD; Brolin RE; Ebert EC
Immunology; 2000 Oct; 101(2):185-90. PubMed ID: 11012771
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
Spertini F; Spits H; Geha RS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcal enterotoxin microbial superantigens.
Johnson HM; Russell JK; Pontzer CH
FASEB J; 1991 Sep; 5(12):2706-12. PubMed ID: 1916093
[TBL] [Abstract][Full Text] [Related]
40. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
